Retatrutide

What is Retatrutide? Retatrutide is a synthetic research peptide engineered to act on three receptor pathways at once — GLP-1, GIP, and glucagon. That triple-agonist footprint makes it structurally distinct from dual agonists such as tirzepatide, and one of the most-studied molecules in contemporary metabolic-pathway research.

Why researchers choose it A single backbone that engages three receptors lets researchers probe overlapping signalling cascades without co-administering multiple compounds — the observed readout reflects the integrated activity being modelled. REPRIME supplies it as a lyophilized powder in 10 mg, 20 mg, and 30 mg vials, so reconstitution timing stays under the researcher's control.

Quality and verification Every batch is HPLC-tested by an independent laboratory at ≥99% purity, and the COA and HPLC trace are published openly on this page and in our Certificates repository. Each vial's insert carries a unique REP-XXXX-XXXX-X code you can confirm at /verify. For laboratory and research use only — not for human consumption.